31.6 F
Indianapolis
Saturday, January 16, 2021

Minority women screened for chlamydia at higher rate

More by this author

Police have a legitimacy problem to address first

Lauryn Smith sat on the sidewalk during a sit-in on Indiana Avenue earlier in September and thought about whether it’s actually possible for police...

City leaders, community members disagree on demilitarization

When protesters came face to face with Indianapolis Metropolitan Police Department (IMPD) officers downtown May 30, the anger and confusion from the crowd was...

IU School of Medicine to participate in COVID-19 vaccine trial

Researchers at the Indiana University School of Medicine will be looking for volunteers to receive a two-round COVID-19 vaccination when the trial resumes in...

Substance use disorder stigma: the ‘scarlet letter’

They say when white folks catch a cold, Black folks get pneumonia. The saying usually applies to economic disparities, but what about when white...

Special to the Recorder

A new study from the Indiana University School of Medicine and the Regenstrief Institute has found that Black and especially Hispanic young women are screened for chlamydia at a significantly higher rate than young white women. The discrepancy in screening rates may contribute to nationwide reporting of higher rates of this sexually-transmitted disease among minority young women.

The research, which used data from more than 40,000 visits to health care facilities, appears in the February issue of the journal Pediatrics, published online ahead of print on Jan. 24.

Despite a recommendation from the U.S. Preventive Services Task Force to annually screen all sexually-active young women for this disease, only about half of sexually active women, ages 14 to 25, who receive health care are screened appropriately, doctors say. The IU and Regenstrief researchers found that Black young women were 2.7 times more likely and Hispanic young women 9.7 times more likely to be screened for chlamydia, compared with white young women.

In addition to race or ethnicity, the researchers found that screening likelihood varied by insurance status and also by age. Women with public insurance had greater odds of chlamydia testing, compared with women with private insurance.

“For some common conditions like breast cancer, white women are more likely to receive a screening test like mammography. For chlamydia infections – which are highly stigmatized STDs – white women are less likely, while minority women are more likely, to receive screening. This may mean that providers make judgments about a woman’s likelihood of infection based on her race or ethnicity. Yet in an asymptomatic condition like chlamydia, all sexually active young women should be screened,” said study first author Dr. Sarah E. Wiehe, assistant professor of pediatrics at the IU School of Medicine and a Regenstrief Institute affiliated scientist.

A medical history of STDs was more important than race or ethnicity or insurance status in terms of differences in chlamydia screening. Young women who had a previous STD were more likely to be screened for chlamydia, no matter their race or ethnicity, and differences by race or ethnicity in testing decreased substantially in this subgroup. The same was not true for young women who had been pregnant in the past. After a pregnancy, young minority women were much more likely (24 times for Hispanic women and 4 times for black women) to be screened than young white women.

“Even when we accounted for provider-level differences in testing patterns, the bias to screen Black and Hispanic young women persisted,” said Wiehe, who also is a pediatrician and health services researcher. “We must encourage pediatricians, internists, family medicine physicians and gynecologists to screen all sexually-active young women under their care. Chlamydia is a serious and usually asymptomatic disease that may have serious health repercussions.”

Co-authors of “Chlamydia Screening Among Adolescents and Young Women: Individual- and Provider-Level Differences in Testing Rates” in addition to Dr. Wiehe are Marc B. Rosenman, M.D., M.S., and Barry P. Katz, Ph.D., of the IU School of Medicine and the Regenstrief Institute, Jane Wang, Ph.D., of the Regenstrief Institute, and J. Dennis Fortenberry, M.D., M.S., of the IU School of Medicine. The study was funded by the National Institutes of Health and the Clarian Value Fund.

The IU School of Medicine and the Regenstrief Institute are located at the campus of Indiana University-Purdue University Indianapolis.

- Advertisement -

Upcoming Online Townhalls

- Advertisement -

Subscribe to our newsletter

To be updated with all the latest local news.

Stay connected

16,331FansLike
3,142FollowersFollow
5,989FollowersFollow
14SubscribersSubscribe

Related articles

Popular articles

It’s on you, white America

The insurrection at the Capitol is as American as apple pie. I know many in white America have a...

Carson targeted in Capitol terrorist attack

Rep. André Carson was targeted during the attack on the Capitol Jan. 6. A note written by terrorist Lonnie Coffman that categorized...

Our Future is Powerful Voices

This program is closing the opportunity gap for black and brown students. Find out how you can participate.

Amid the pandemic, more Black families on the brink of homelessness

Three times a week, an Uber ride on Indianapolis’ east side helps to save the life of bright-eyed, 11-year-old Jay’Shawn Roberson.

Indiana GOP kicks off diversity leadership series

The Indiana GOP’s effort to develop future leaders from diverse communities begins this month. The Indiana Republican Diversity Leadership...
Español + Translate »
Skip to content